SB 1083

  • Maryland Senate Bill
  • 2018 Regular Session
  • Introduced in Senate
  • Passed Senate Apr 03, 2018
  • Passed House Apr 07, 2018
  • Governor

Public Health - Prescription Drug Monitoring Program - Revisions

Votes


Actions


Apr 09, 2018

Senate

Senators Klausmeier, Jennings, and Rosapepe

Senate

Conference Committee Appointed

Senate

Senate Requests House Recede

Senate

Senate Refuses to Concur - House Amendments

Apr 07, 2018

House

Favorable with Amendments {986881/1 Report Adopted

House

Favorable with Amendments Report by Health and Government Operations

House

Third Reading Passed with Amendments (135-0)

House

Motion Rules Suspended two readings same day (Delegate Bromwell) Adopted (132-1)

House

Second Reading Passed with Amendments

Apr 05, 2018

House

Hearing 4/06 at 1:00 p.m.

Apr 04, 2018

House

Rereferred to Health and Government Operations

Apr 03, 2018

House

First Reading House Rules and Executive Nominations

Senate

Third Reading Passed (45-0)

Apr 02, 2018

Senate

Favorable with Amendments Report by Finance

Senate

Second Reading Passed with Amendments

Senate

Favorable with Amendments {677071/1 Report Adopted

Feb 28, 2018

Senate

Hearing canceled

Senate

Hearing 3/20 at 1:00 p.m.

Feb 21, 2018

Senate

Hearing 3/22 at 1:00 p.m.

Feb 15, 2018

Senate

Rereferred to Finance

Feb 12, 2018

Senate

First Reading Senate Rules

Bill Text

Bill Text Versions Format
Bill Text PDF PDF

Related Documents

Document Format
House Health and Government Operations Committee Vote PDF
Senate Finance Committee Vote PDF
Fiscal and Policy Note (Revised) PDF
Amendments House - (Health and Government Operations) {986881/01 Adopted PDF
Amendments Senate - (Finance) {677071/01 Adopted PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Maryland General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.